She completed her PhD in the field of Pharmacogenomics at Postgraduate Institute of Medical Education and Research in Chandigarh, India and Post-doctoral training at St. Jude Children’s Research Hospital, Memphis. Her research has been funded from NIH/NCI since 2008 and focuses on “Identification, characterization and clinical validation of genomic/epigenomic markers predictive of therapeutic outcome in cancer patients specifically Acute Myeloid Leukemia. Her research spans from preclinical basic research comprising the discovery phase to translational/clinical phase in patient populations from multi-institute clinical trials.